ELITE PHARMACEUTICALS INC /NV/ (ELTP)
Form 4 sales, Form 144 notices and lockup dates
- Latest sale
- $496k
- Oct 2 · No plan
- Form 4 sales
- 123
- On record
- Form 144 notices
- 3
- Proposed sales
- Sold, last 30 days
- None
- No Form 4 sale
- Sold, last 90 days
- None
- No Form 4 sale
- Next unlock
- None
- No lockup ahead
Lockups
No lockup on record.
Sales by reason
Timeline
- Oct 2, 2025No plan
Plassche Douglas, EVP Operations, sold 18.6% of their holdings
$496k800,000 shares at $0.62
- Aug 22, 2025No plan
Elite Pharmaceuticals INC /nv/, EVP Operations, sold 21.7% of their holdings
$260k500,000 shares at $0.52
- Aug 22, 2025Notice
Plassche Douglas, EVP Operations, filed a notice to sell 100,000 shares
$555k100,000 shares
- Jul 8, 2025No plan
Plassche Douglas, EVP Operations, sold 8% of their holdings
$116k200,000 shares at $0.58
- Jul 8, 2025Notice
Plassche Douglas, EVP Operations, filed a notice to sell 500,000 shares
$303k500,000 shares
- Oct 24, 2024Unusual
Plassche Douglas, SVP of Operations, sold 100% of their holdings
$562k1.1M shares at $0.50
- Oct 23, 2024Notice
Plassche Douglas, EVP Operations, filed a notice to sell 1.1M shares
$680k1.1M shares
- Mar 18, 2016Plan not stated
Treppel Jerry, Other, sold 6.9% of their holdings
$197k570,520 shares at $0.35
- Feb 24, 2016Plan not stated
Treppel Jerry, Other, sold 2.4% of their holdings
$63k200,456 shares at $0.31
- Feb 17, 2016Plan not stated
Treppel Jerry, Other, sold 9.8% of their holdings
$301k909,878 shares at $0.33
Every transaction
| Traded | Filed | Stock | Name | Role | What | Amount | Price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 9, 2026 | Oct 19, 2026 | ELTP | Dash Barry H | Director | Bought | 100,000 | $0.26 | $26k | 3.4M | SEC |
| Aug 19, 2026 | Sep 10, 2026 | ELTP | Dash Barry H | Director | Bought | 30,000 | $0.29 | $9k | 3.3M | SEC |
| Jan 9, 2026 | Jan 13, 2026 | ELTP | Plassche Douglas | EVP Operations | Exercised or settledStock Options (right to buy) | 2.5M | 0 | SEC | ||
| Jan 9, 2026 | Jan 13, 2026 | ELTP | Plassche Douglas | EVP Operations | Exercised options | 2.5M | $0.0300 | $75k | 6M | SEC |
| Oct 2, 2025 | Oct 3, 2025 | ELTP | Plassche Douglas | EVP Operations | Sold | 800,000 | $0.62 | $496k | 3.5M | SEC |
| Aug 25, 2025 | Aug 26, 2025 | ELTP | Elite Pharmaceuticals INC /nv/ | EVP Operations | Exercised or settledStock Options (right to buy) | 2.5M | 2.5M | SEC | ||
| Aug 25, 2025 | Aug 26, 2025 | ELTP | Elite Pharmaceuticals INC /nv/ | EVP Operations | Exercised options | 2.5M | $0.0300 | $75k | 4.3M | SEC |
| Aug 22, 2025 | Aug 26, 2025 | ELTP | Elite Pharmaceuticals INC /nv/ | EVP Operations | Sold | 500,000 | $0.52 | $260k | 1.8M | SEC |
| Jul 10, 2025 | Jul 25, 2025 | ELTP | Kirkov Kirko | Chief Commercial Officer | Bought | 16,366 | $0.59 | $10k | 16,366 | SEC |
| Jul 8, 2025 | Jul 10, 2025 | ELTP | Plassche Douglas | EVP Operations | Sold | 200,000 | $0.58 | $116k | 2.3M | SEC |
| Jul 3, 2025 | Jul 8, 2025 | ELTP | Plassche Douglas | EVP Operations | Exercised or settledStock Options (right to buy) | 2.5M | 5M | SEC | ||
| Jul 3, 2025 | Jul 8, 2025 | ELTP | Plassche Douglas | EVP Operations | Exercised options | 2.5M | $0.0300 | $75k | 2.5M | SEC |
| Oct 24, 2024 | Oct 28, 2024 | ELTP | Plassche Douglas | SVP of Operations | Sold | 1.1M | $0.50 | $562k | 0 | SEC |
| Mar 29, 2024 | Apr 2, 2024 | ELTP | Hakim Nasrat A | CEO, President | Awarded | 49.5M | 217M | SEC | ||
| Dec 29, 2023 | Dec 29, 2023 | ELTP | Hakim Nasrat A | CEO, President | Awarded | 2.2M | $0.0700 | $156k | 2.2M | SEC |
| Nov 22, 2023 | Nov 27, 2023 | ELTP | Whitnell Jeffrey A | Director | Awarded | 547,657 | $0.0400 | $22k | 3.2M | SEC |
| Nov 22, 2023 | Nov 27, 2023 | ELTP | Caskey Davis S | Director | Awarded | 547,657 | $0.0400 | $22k | 2M | SEC |
| Nov 22, 2023 | Nov 27, 2023 | ELTP | Dash Barry H | Director | Awarded | 547,657 | $0.0400 | $22k | 3.2M | SEC |
| Jan 3, 2023 | Jun 26, 2023 | ELTP | Plassche Douglas | Executive VP Operations | AwardedOptions | 7.5M | $0.0300 | $225k | 7.5M | SEC |
| Sep 6, 2022 | Nov 14, 2022 | ELTP | Kirkov Kirko | Chief Commercial Officer | AwardedOptions | 3M | $0.0400 | $120k | 3M | SEC |
| Aug 28, 2022 | Aug 29, 2022 | ELTP | Whitnell Jeffrey A | Director | Awarded | 459,536 | $0.0400 | $18k | 2.6M | SEC |
| Aug 28, 2022 | Aug 29, 2022 | ELTP | Caskey Davis S | Director | Awarded | 459,536 | $0.0400 | $18k | 1.5M | SEC |
| Aug 28, 2022 | Aug 29, 2022 | ELTP | Dash Barry H | Director | Awarded | 459,536 | $0.0400 | $18k | 2.7M | SEC |
| May 16, 2022 | Jul 7, 2022 | ELTP | Chen Robert C J | CFO, Secretary, Treasurer | AwardedOptions | 900,000 | $0.0400 | $36k | 900,000 | SEC |
| Jun 30, 2021 | Jul 1, 2021 | ELTP | Whitnell Jeffrey A | Director | Awarded | 295,570 | $0.0700 | $21k | 2.2M | SEC |
| Jun 30, 2021 | Jul 1, 2021 | ELTP | Caskey Davis S | Director | Awarded | 295,570 | $0.0700 | $21k | 1M | SEC |
| Jun 30, 2021 | Jul 1, 2021 | ELTP | Dash Barry H | Director | Awarded | 295,570 | $0.0700 | $21k | 2.2M | SEC |
| May 17, 2021 | Jul 7, 2021 | ELTP | Bregman Marc | CFO, Secretary, Treasurer | AwardedOptions | 300,000 | $0.0600 | $18k | 300,000 | SEC |
| Aug 24, 2020 | Aug 26, 2020 | ELTP | Hakim Nasrat A | CEO & President | ConvertedSeries J Convertible Preferred Shares | 24 | 0 | SEC | ||
| Aug 24, 2020 | Aug 26, 2020 | ELTP | Hakim Nasrat A | CEO & President | Converted | 158M | 167M | SEC | ||
| Aug 20, 2020 | Aug 24, 2020 | ELTP | Plassche Douglas | SVP Operations | Awarded | 71,739 | $0.0900 | $6k | 1.1M | SEC |
| Aug 20, 2020 | Aug 24, 2020 | ELTP | Caskey Davis S | Director | Awarded | 516,781 | $0.0900 | $47k | 746,673 | SEC |
| Aug 20, 2020 | Aug 24, 2020 | ELTP | Whitnell Jeffrey A | Director | Awarded | 516,781 | $0.0900 | $47k | 1.9M | SEC |
| Aug 20, 2020 | Aug 24, 2020 | ELTP | Dash Barry H | Director | Awarded | 516,781 | $0.0900 | $47k | 1.9M | SEC |
| Jun 30, 2020 | Jul 6, 2020 | ELTP | Plassche Douglas | SVP of Operations | Awarded | 574,597 | $0.0900 | $52k | 1.1M | SEC |
| Feb 26, 2018 | Feb 27, 2018 | ELTP | Pfeifer Eugene M | Director | Awarded | 161,374 | $0.12 | $19k | 233,414 | SEC |
| Feb 26, 2018 | Feb 27, 2018 | ELTP | Plassche Douglas | SVP of Operations | Awarded | 201,717 | $0.12 | $24k | 487,596 | SEC |
| Feb 26, 2018 | Feb 27, 2018 | ELTP | Ward Carter Julian | CFO, Sec., Treas. | Awarded | 242,060 | $0.12 | $29k | 2.1M | SEC |
| Feb 26, 2018 | Feb 27, 2018 | ELTP | Whitnell Jeffrey A | Director | Awarded | 161,374 | $0.12 | $19k | 1.4M | SEC |
| Feb 26, 2018 | Feb 27, 2018 | ELTP | Dash Barry H | Director | Awarded | 161,374 | $0.12 | $19k | 1.4M | SEC |
| Feb 26, 2018 | Feb 27, 2018 | ELTP | Caskey Davis S | Director | Awarded | 161,374 | $0.12 | $19k | 229,892 | SEC |
| Apr 28, 2017 | May 3, 2017 | ELTP | Hakim Nasrat A | CEO & President | OtherSeries J Convertible Preferred Shares | 79M | $0.30 | $24M | 79M | SEC |
| Apr 28, 2017 | May 3, 2017 | ELTP | Hakim Nasrat A | CEO & President | Other | 158M | 9.1M | SEC | ||
| Feb 23, 2017 | Feb 27, 2017 | ELTP | Pfeifer Eugene M | Director | Awarded | 72,040 | $0.20 | $14k | 72,040 | SEC |
| Feb 23, 2017 | Feb 27, 2017 | ELTP | Caskey Davis S | Director | Awarded | 68,518 | $0.20 | $14k | 68,518 | SEC |
| Feb 23, 2017 | Feb 27, 2017 | ELTP | Plassche Douglas | SVP of Operations | Awarded | 110,849 | $0.23 | $25k | 285,879 | SEC |
| Feb 23, 2017 | Feb 27, 2017 | ELTP | Ward Carter Julian | Director | Awarded | 133,019 | $0.23 | $31k | 1.9M | SEC |
| Feb 23, 2017 | Feb 27, 2017 | ELTP | Whitnell Jeffrey A | Director | Awarded | 88,679 | $0.23 | $20k | 1.2M | SEC |
| Feb 23, 2017 | Feb 27, 2017 | ELTP | Dash Barry H | Director | Awarded | 88,679 | $0.23 | $20k | 1.3M | SEC |
| Feb 23, 2017 | Feb 27, 2017 | ELTP | Hakim Nasrat A | CEO & President | Awarded | 2.2M | $0.23 | $510k | 24.1M | SEC |
Sales, notices and lockups (126)
Export watchlist as CSV| Source | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 2, 2025 | Oct 3, 2025 | Plassche Douglas | ELTP | EVP Operations | Form 4 sale | 800,000 | $496k | 18.6% | No plan | SEC |
| Aug 22, 2025 | Aug 26, 2025 | Elite Pharmaceuticals INC /nv/ | ELTP | EVP Operations | Form 4 sale | 500,000 | $260k | 21.7% | No plan | SEC |
| Aug 22, 2025 | Aug 22, 2025 | Plassche Douglas | ELTP | EVP Operations | Form 144 notice | 100,000 | $555k | Notice | SEC | |
| Jul 8, 2025 | Jul 10, 2025 | Plassche Douglas | ELTP | EVP Operations | Form 4 sale | 200,000 | $116k | 8.0% | No plan | SEC |
| Jul 8, 2025 | Jul 8, 2025 | Plassche Douglas | ELTP | EVP Operations | Form 144 notice | 500,000 | $303k | Notice | SEC | |
| Oct 24, 2024 | Oct 28, 2024 | Plassche Douglas | ELTP | SVP of Operations | Form 4 sale | 1.1M | $562k | 100.0% | Unusual | SEC |
| Oct 23, 2024 | Oct 23, 2024 | Plassche Douglas | ELTP | EVP Operations | Form 144 notice | 1.1M | $680k | Notice | SEC | |
| Mar 18, 2016 | Mar 21, 2016 | Treppel Jerry | ELTP | Other | Form 4 sale | 570,520 | $197k | 6.9% | Plan not stated | SEC |
| Feb 24, 2016 | Feb 24, 2016 | Treppel Jerry | ELTP | Other | Form 4 sale | 200,456 | $63k | 2.4% | Plan not stated | SEC |
| Feb 17, 2016 | Feb 18, 2016 | Treppel Jerry | ELTP | Other | Form 4 sale | 909,878 | $301k | 9.8% | Plan not stated | SEC |
| Nov 18, 2015 | Nov 18, 2015 | Treppel Jerry | ELTP | Chairman of Board | Form 4 sale | 150,000 | $45k | 1.6% | Plan not stated | SEC |
| Apr 27, 2015 | Apr 28, 2015 | Plassche Douglas | ELTP | Executive VP of Operations | Form 4 sale | 85,530 | $21k | 53.9% | Unusual | SEC |
| May 9, 2014 | May 13, 2014 | Narine Jeenarine | ELTP | Director, 10% owner | Form 4 sale | 329,437 | $125k | 5.6% | Plan not stated | SEC |
| Apr 2, 2014 | Apr 4, 2014 | Narine Jeenarine | ELTP | Director, 10% owner | Form 4 sale | 147,664 | $61k | 2.5% | Plan not stated | SEC |
| Mar 27, 2014 | Mar 31, 2014 | Narine Jeenarine | ELTP | Director, 10% owner | Form 4 sale | 190,172 | $82k | 3.1% | Plan not stated | SEC |
| Mar 11, 2014 | Mar 17, 2014 | Narine Jeenarine | ELTP | Director, 10% owner | Form 4 sale | 239,367 | $144k | 1.6% | Plan not stated | SEC |
| Mar 11, 2014 | Mar 17, 2014 | Nigalaye Ashok G | ELTP | Chief Scientific Officer | Form 4 sale | 239,367 | $144k | 1.2% | Plan not stated | SEC |
| Mar 11, 2014 | Mar 17, 2014 | Epic Pharma LLC | ELTP | 10% owner | Form 4 sale | 239,367 | $144k | 0.4% | Plan not stated | SEC |
| Mar 11, 2014 | Mar 17, 2014 | Epic Investments, LLC | ELTP | 10% owner | Form 4 sale | 239,367 | $144k | 0.4% | Plan not stated | SEC |
| Mar 7, 2014 | Mar 10, 2014 | Narine Jeenarine | ELTP | Director, 10% owner | Form 4 sale | 1.8M | $1.4M | 10.9% | Unusual | SEC |
| Mar 7, 2014 | Mar 10, 2014 | Nigalaye Ashok G | ELTP | Chief Scientific Officer | Form 4 sale | 1.8M | $1.4M | 8.2% | Unusual | SEC |
| Mar 7, 2014 | Mar 10, 2014 | Epic Pharma LLC | ELTP | 10% owner | Form 4 sale | 1.8M | $1.4M | 2.6% | Unusual | SEC |
| Mar 7, 2014 | Mar 10, 2014 | Epic Investments, LLC | ELTP | 10% owner | Form 4 sale | 1.8M | $1.4M | 2.6% | Unusual | SEC |
| Jan 13, 2014 | Jan 17, 2014 | Narine Jeenarine | ELTP | Director, 10% owner | Form 4 sale | 805,583 | $145k | 5.0% | Plan not stated | SEC |
| Jan 13, 2014 | Jan 17, 2014 | Nigalaye Ashok G | ELTP | Chief Scientific Officer | Form 4 sale | 805,583 | $145k | 3.7% | Plan not stated | SEC |
| Jan 13, 2014 | Jan 17, 2014 | Epic Pharma LLC | ELTP | 10% owner | Form 4 sale | 805,583 | $145k | 1.1% | Plan not stated | SEC |
| Jan 13, 2014 | Jan 17, 2014 | Epic Investments, LLC | ELTP | 10% owner | Form 4 sale | 805,538 | $145k | 1.1% | Plan not stated | SEC |
| Dec 5, 2013 | Dec 16, 2013 | Epic Investments, LLC | ELTP | 10% owner | Form 4 sale | 298,626 | $39k | 0.4% | Plan not stated | SEC |
| Dec 5, 2013 | Dec 13, 2013 | Narine Jeenarine | ELTP | Director, 10% owner | Form 4 sale | 298,626 | $39k | 1.9% | Plan not stated | SEC |
| Dec 5, 2013 | Dec 13, 2013 | Nigalaye Ashok G | ELTP | Chief Scientific Officer | Form 4 sale | 298,626 | $39k | 1.4% | Plan not stated | SEC |
| Dec 5, 2013 | Dec 13, 2013 | Epic Pharma LLC | ELTP | 10% owner | Form 4 sale | 298,626 | $39k | 0.4% | Plan not stated | SEC |
| Dec 2, 2013 | Dec 4, 2013 | Nigalaye Ashok G | ELTP | Chief Scientific Officer | Form 4 sale | 100,000 | $13k | 0.5% | Plan not stated | SEC |
| Dec 2, 2013 | Dec 4, 2013 | Epic Pharma LLC | ELTP | 10% owner | Form 4 sale | 100,000 | $13k | 0.1% | Plan not stated | SEC |
| Dec 2, 2013 | Dec 4, 2013 | Epic Investments, LLC | ELTP | 10% owner | Form 4 sale | 100,000 | $13k | 0.1% | Plan not stated | SEC |
| Nov 27, 2013 | Nov 29, 2013 | Narine Jeenarine | ELTP | Director, 10% owner | Form 4 sale | 421,000 | $51k | 2.6% | Plan not stated | SEC |
| Nov 27, 2013 | Nov 29, 2013 | Nigalaye Ashok G | ELTP | Chief Scientific Officer | Form 4 sale | 421,000 | $51k | 1.9% | Plan not stated | SEC |
| Nov 27, 2013 | Nov 29, 2013 | Epic Pharma LLC | ELTP | 10% owner | Form 4 sale | 421,000 | $51k | 0.6% | Plan not stated | SEC |
| Nov 27, 2013 | Nov 29, 2013 | Epic Investments, LLC | ELTP | 10% owner | Form 4 sale | 421,000 | $51k | 0.6% | Plan not stated | SEC |
| Nov 19, 2013 | Nov 19, 2013 | Narine Jeenarine | ELTP | Director, 10% owner | Form 4 sale | 2M | $237k | 11.1% | Unusual | SEC |
| Nov 19, 2013 | Nov 19, 2013 | Nigalaye Ashok G | ELTP | Chief Scientific Officer | Form 4 sale | 2M | $237k | 8.4% | Unusual | SEC |
| Nov 19, 2013 | Nov 19, 2013 | Epic Pharma LLC | ELTP | 10% owner | Form 4 sale | 2M | $237k | 2.7% | Plan not stated | SEC |
| Nov 19, 2013 | Nov 19, 2013 | Epic Investments, LLC | ELTP | 10% owner | Form 4 sale | 2M | $237k | 2.7% | Unusual | SEC |
| Nov 6, 2013 | Nov 8, 2013 | Narine Jeenarine | ELTP | Director, 10% owner | Form 4 sale | 122,200 | $15k | 0.7% | Plan not stated | SEC |
| Nov 6, 2013 | Nov 8, 2013 | Nigalaye Ashok G | ELTP | Chief Scientific Officer | Form 4 sale | 122,200 | $15k | 0.5% | Plan not stated | SEC |
| Nov 6, 2013 | Nov 8, 2013 | Epic Pharma LLC | ELTP | 10% owner | Form 4 sale | 122,200 | $15k | 0.2% | Plan not stated | SEC |
| Nov 6, 2013 | Nov 8, 2013 | Epic Investments, LLC | ELTP | 10% owner | Form 4 sale | 122,200 | $15k | 0.2% | Plan not stated | SEC |
| Oct 29, 2013 | Oct 30, 2013 | Narine Jeenarine | ELTP | Director, 10% owner | Form 4 sale | 204,820 | $14k | 1.2% | Plan not stated | SEC |
| Oct 29, 2013 | Oct 30, 2013 | Nigalaye Ashok G | ELTP | Chief Scientific Officer | Form 4 sale | 279,300 | $36k | 1.2% | Plan not stated | SEC |
| Oct 29, 2013 | Oct 30, 2013 | Epic Pharma LLC | ELTP | 10% owner | Form 4 sale | 931,000 | $121k | 1.2% | Plan not stated | SEC |
| Oct 29, 2013 | Oct 30, 2013 | Epic Investments, LLC | ELTP | 10% owner | Form 4 sale | 931,000 | $121k | 1.2% | Plan not stated | SEC |